J&J's Talcum Powder Goes on Trial in Ovarian Cancer Lawsuits

  • Company asserts safety of products containing cosmetic talc
  • St. Louis trial's outcome could determine fate of 1,200 cases

Johnson & Johnson, already facing lawsuits over products from surgical mesh to antipsychotic drugs, began trial Tuesday over claims the talcum powder it marketed to women gave some of them cancer.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.